Inhibition of Phosphate Transporters Ameliorates the Inflammatory and Necrotic Side Effects of the Nitrogen-Containing Bisphosphonate Zoledronate in Mice-Reference-Cited by-同舟云学术

Inhibition of Phosphate Transporters Ameliorates the Inflammatory and Necrotic Side Effects of the Nitrogen-Containing Bisphosphonate Zoledronate in Mice

Published:2013 Issue:2 Volume:231 Page:145-158
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Okada Satoru¹²,Kiyama Tomomi¹³,Sato Eri¹,Tanaka Yukinori¹,Oizumi Takefumi²,Kuroishi Toshinobu¹,Takahashi Tetsu²,Sasaki Keiichi³,Sugawara Shunji¹,Endo Yasuo¹

Affiliation:

1. Division of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku University

2. Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University

3. Division of Advanced Prosthetic Dentistry, Graduate School of Dentistry, Tohoku University

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/tjem/231/2/231_145/_pdf

Reference52 articles.

1. Adami, S. & Zamberlan, N. (1996) Adverse effects of bisphosphonate. A comparative review. Drug Saf., 14, 158-170.

2. Anastasilakis, A.D., Goulis, D.G., Kita, M. & Avramidis, A. (2007) Oral bisphosphonate adverse effects in 849 patients with metabolic bone diseases. Hormones (Athens), 6, 233-341.

3. Anderson, C.M.H. & Thwaites, D.T. (2011) Hijacking solute carriers for proton-coupled drug transport. Physiology, 25, 364-377.

4. Buxton, I.L.O. (2006) Pharmakokinetics and pharmacodynamics: the dynamics of drug absorption, distribution, action, and elimination. In Goodman and Gilman’s the pharmacological basis of therapeutics, 11^th edition, edited by Brunton, L.L., Lazo, J.S. & Parker, K.L. McGraw-Hill, New York, NY, pp. 1-39.

5. Chrisp, P. & Clissold, S.P. (1991) Foscarnet: a review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs, 41, 104-129.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clodronate Reduces ATP-Containing Microvesicle Releasing Induced by Nociceptive Stimuli in Human Keratinocytes;International Journal of Molecular Sciences;2024-08-02

2. Osteonecrosis of the jaw in a patient treated with alendronate and then denosumab: A case of dramatic amelioration by minocycline and then etidronate;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2024-08

3. Bisphosphonates-related tendinopathies and ligament disorders: Cases analysis from the U.S. Food and Drug Administration adverse event reporting system;Bone;2023-12

4. Histamine acts via H4-receptor stimulation to cause augmented inflammation when lipopolysaccharide is co-administered with a nitrogen-containing bisphosphonate;Inflammation Research;2022-10-29

5. Release of Nitrogen-Containing Bisphosphonates (NBPs) from Hydroxyapatite by Non-NBPs and by Pyrophosphate;Biological and Pharmaceutical Bulletin;2021-11-01